Chief Medical Officer
Dr. Salvatore Viscomi leads GoodCell’s product line of genetic and biomarker testing, developing a healthcare platform that harnesses the power of blood to both inform and restore health.
Salvatore is a practicing physician, instructor and an entrepreneur. He spent 14 years as a member of Harvard Medical School’s faculty and concurrently as a clinician at Brigham and Women’s Hospital. In that capacity, he held various administrative and clinical roles including Director of Admissions of a Harvard Residency Program.
As an expert in medical imaging, Salvatore has published and presented nationally and internationally. Dr. Viscomi co-founded Brigham NightWatch, the first academic teleradiology network in the world. In addition, Dr. Viscomi served as an executive and board member of FreMon Scientific where he led the development of a next-generation blood product management solution through FDA approval and ultimately to market.
Dr. Viscomi began his path towards medicine while at Columbia University, earning a B.A. in Neuropsychology. Salvatore completed his residency and specialization at Harvard Medical School.
He also serves on the mission delivery committee of Make-A-Wish Foundation. In 2016, Dr. Viscomi completed the Executive Education Program at Harvard Business School.